“Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2)”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s96. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/1066.